Results 171 to 180 of about 427,218 (207)
Some of the next articles are maybe not open access.
Regulation of G protein-coupled receptor kinase 2
2002Publisher Summary G protein-coupled receptor kinase 2 (GRK2) was originally termed a “β-adrenergic receptor kinase” (βARK) because it was purified as a kinase of the adrenergic β 2 receptor, and the adrenergic β 2 receptor was the only known substrate of GRK2. GRK2 is now known to phosphorylate different kinds of G protein-coupled receptors (GPCRs),
Tatsuya, Haga +4 more
openaire +2 more sources
G Protein‐Coupled Receptor Kinases
Journal of Neurochemistry, 1994T, Haga, K, Haga, K, Kameyama
openaire +2 more sources
Targeting G protein-coupled receptor kinases (GRKs) to G protein-coupled receptors.
Current opinion in endocrine and metabolic researchG protein-coupled receptors (GPCRs) interact with three protein families following agonist binding: heterotrimeric G proteins, G protein-coupled receptor kinases (GRKs) and arrestins. GRK-mediated phosphorylation of GPCRs promotes arrestin binding to uncouple the receptor from G protein, a process called desensitization, and for many GPCRs, arrestin ...
Sarah M, Sulon, Jeffrey L, Benovic
openaire +1 more source
Critical care management of chimeric antigen receptor T‐cell therapy recipients
Ca-A Cancer Journal for Clinicians, 2022Alexander Shimabukuro-Vornhagen +2 more
exaly
Delineating the conformational landscape of the adenosine A2A receptor during G protein coupling
Cell, 2021Shuya Kate Huang +2 more
exaly
A review of cancer immunotherapy toxicity
Ca-A Cancer Journal for Clinicians, 2020Lucy Boyce Kennedy
exaly
Receptor-interacting protein kinase 1 (RIPK1) as a therapeutic target
Nature Reviews Drug Discovery, 2020Lauren Mifflin, Junying Yuan
exaly

